ADMINISTRATION OF HYPOXIA ACTIVATED PRODRUGS AND ANTIANGIOGENIC AGENTS FOR THE TREATMENT OF CANCER
- 专利权人:
- 发明人:
- 申请号：
- EP11807356.8
- 公开号：
- EP2593139B1
- 申请日:
- 2011.07.11
- 申请国别(地区):
- EP
- 年份:
- 2017
- 代理人:
- 摘要：
- Administration of a hypoxia activated prodrug in combination with an antiangiogenic agent is useful for treating cancer.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- HYPOXIA ACTIVATED PRODRUGS AND MTOR INHIBITORS FOR TREATING CANCER
- Administration of hypoxia activated prodrug in combination with CHK1 inhibitor to treat cancer
- ADMINISTRATION OF HYPOXIA ACTIVATED PRODRUGS AND ANTIANGIOGENIC AGENTS FOR THE TREATMENT OF CANCER
- 암 치료를 위한 저산소증 활성 프로드러그와 항혈관형성제의 투여
- ADMINISTRATION OF HYPOXIA ACTIVATED PRODRUGS AND ANTIANGIOGENIC AGENTS FOR THE TREATMENT OF CANCER
